Analyst Ratings for PAVmed (PAVM)
PAVM Rating Summary
PAVM Price Target Summary
- Highest: $7.00 (Ascendiant Capital)
- Lowest: $1.50 (Maxim Group)
- Average: $2.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.88 (+858.3%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$2.88 (+858.3%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/20/2023 | Cantor Fitzgerald | Ross Osborn | Downgrade | Neutral (Overweight) |
1.50 (4.00) |
0.46 (0.30) |
-34.78% | Details |
| 11/5/2020 | Ascendiant Capital » Updated 9/6/2023 |
Edward Woo | New Coverage | Buy (N/A) |
7.00 (7.50) |
1.80 (0.30) |
-83.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
